Susquehanna International Group, LLP Kronos Bio, Inc. Transaction History
Susquehanna International Group, LLP
- $568 Billion
- Q1 2025
A detailed history of Susquehanna International Group, LLP transactions in Kronos Bio, Inc. stock. As of the latest transaction made, Susquehanna International Group, LLP holds 155,188 shares of KRON stock, worth $136,565. This represents 0.0% of its overall portfolio holdings.
Number of Shares
155,188
Previous 121,868
27.34%
Holding current value
$136,565
Previous $115,000
10.43%
% of portfolio
0.0%
Previous 0.0%
Shares
12 transactions
Others Institutions Holding KRON
# of Institutions
47Shares Held
16.6MCall Options Held
51.2KPut Options Held
0-
Vanguard Group Inc Valley Forge, PA1.92MShares$1.69 Million0.0% of portfolio
-
Partners Capital Investment Group, LLP Boston, MA1.45MShares$1.27 Million0.02% of portfolio
-
Alphabet Inc. Mountain View, CA1.44MShares$1.27 Million0.11% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny1.43MShares$1.25 Million0.0% of portfolio
-
Tang Capital Management LLC San Diego, CA1.35MShares$1.18 Million0.07% of portfolio
About Kronos Bio, Inc.
- Ticker KRON
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 56,769,100
- Market Cap $50M
- Description
- Kronos Bio, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of novel cancer therapeutics. The company's product engine focuses on dysregulated transcription factors and the transcriptional regulatory networks that drive oncogenic activity. Its lead product candidate is entospletinib (ENTO), is an orally...